ANA380: Final Phase I/II data

In a double-blind, placebo-controlled, dose-escalation, Chinese and Korean Phase

Read the full 98 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE